{"id":"W4402103596","doi":"10.1016/j.jaad.2024.07.359","title":"53928 Tapinarof Cream 1% Once Daily: Interim Analysis of ADORING 3 Phase 3 Long-term Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Probity Medical Research; University of British Columbia; Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Interim; Interim analysis; Term (time); Extension (predicate logic); Dermatology; Pediatrics; Clinical trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002594683,0.001505835,0.003226044,0.000356333,0.0004480488,0.001579053,0.0008429165,0.001256571,0.008038824],"category_scores_gemma":[0.001361881,0.0004713727,0.003161959,0.0003551575,0.0007813132,0.001259278,0.0004002238,0.003979349,0.001543089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006094421,"about_ca_system_score_gemma":0.001006606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001144049,"about_ca_topic_score_gemma":0.003247399,"domain_scores_codex":[0.999199,0.0003541332,0.00003675117,0.0001067893,0.00006064344,0.000242735],"domain_scores_gemma":[0.9990356,0.0003115034,0.0001658388,0.0001186008,0.00006930485,0.0002992461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9319648,0.006252778,0.002364916,0.0008455858,0.002248161,0.0001460503,0.0001266791,0.001130547,0.005211357,0.0002861922,0.00329941,0.04612358],"study_design_scores_gemma":[0.8660301,0.1161866,0.01086512,0.0001248916,0.001728209,0.0001509319,0.00007259126,0.001107042,0.0008991089,0.0003948343,0.002403095,0.00003754714],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.972179,0.01305584,0.001307009,0.0009521944,0.0006933713,0.002076118,0.003945003,0.0003202927,0.005471161],"genre_scores_gemma":[0.9806675,0.00403072,0.001611635,0.001471592,0.000363683,0.002174467,0.003325414,0.00006980696,0.006285309],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008038824,"threshold_uncertainty_score":0.02689254,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01363614635000783,"score_gpt":0.3343800580994721,"score_spread":0.3207439117494643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}